Israeli-founded Emendo Biotherapeutics, based in New York, utilizes protein engineering for precision gene editing, to treat certain genetic disorders and diseases. It has seven treatments in early stages of development. Emendo has just raised $61 million of funding.
https://www.calcalistech.com/ctech/articles/0,7340,L-3777874,00.html